A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Study Summary

The objective of this study is to demonstrate the superiority of MACI (autologous cultured chondrocytes on porcine collagen membrane) versus Bone Marrow Stimulation in the treatment of patients aged 17 to 65 years with symptomatic articular chondral or osteochondral defects of the talus.

Conditions

Chondral Defect Articular Cartilage Defect

Interventions / Drugs

autologous cultured chondrocytes on porcine collagen membrane Bone Marrow Stimulation

View on ClinicalTrials.gov ↗

Sponsor

VCEL

Vericel Corporation

Regenerative Medicine

D37/100

Study Details

Enrollment309 participants

Primary Completion—

Lead SponsorVericel Corporation

Data Retrieved2026-04-11 04:30:51.495441+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.